PointofLaw.com

spacer FORUM FEATURED DISCUSSIONS PoL COLUMNS LEGAL EXPERTS ARTICLES BOOKS LINKS MASTHEAD ADVANCED SEARCH

FORUM

« LeRoy: "Do Courts Create Moral Hazard? When Judges Nullify Employer Liability in Arbitrations: An Empirical Analysis" | Legal Aid, to subprime borrowers' rescue? »

April 14, 2008


New featured column: Jim Copland on FDA pre-emption

With the debate in full swing at the moment, now is the time to catch up with Jim's analysis if you missed it in the Washington Post recently.

Posted by Walter Olson at 5:27 PM | TrackBack (0)



categories:
Products Liability









 

Published by the Manhattan Institute

The Manhattan Insitute's Center for Legal Policy.